Eastman Chemical — Apr 24, 2025 release
Fiscal 2025 first-quarter results · 8-K Item 2.02 · Exhibit 99.1 · 0000915389-25-000099
Showing in the filing
Operating cash flow
“approximately $1.2 billion”
Period
FY2025
Measure
GAAP-tied
Source
Prose
All guidance in this release · 5
Cost reduction target for FY2025
“approximately $75 million net of inflation”
Capital expenditures for FY2025
“around $550 million”
Operating cash flow for FY2025
“approximately $1.2 billion”
Adjusted EPS for Q2 FY2025
“in the range of $1.70 to $1.90”
Adjusted diluted EPS for Q2 FY2025
“$1.70 to $1.90”
Exhibit 99.1 · the passage around this item
… earlier in the release
With an innovative portfolio of specialty products, a diverse set of end markets, and a solid balance sheet, we are well positioned to navigate issues associated with escalating tariffs impacting global trade. In this context, we expect to generate strong operating cash flow of approximately $1.2 billion for full-year 2025 consistent with our track record of delivering cash in varied macro environments. With a broad range of outcomes for the global economy and limited visibility, the company is moving to quarterly adjusted earnings per share guidance. In the second quarter, order patterns for April remain stable with March, and we expect a modest sequential volume increase across our markets, but due to trade uncertainty, not as much as typical. Second quarter also includes headwinds associated with tariffs between the U.S. and China and higher planned maintenance costs. Taking these factors together, second-quarter adjusted EPS is expected to be in the range of $1.70 to $1.90.” The second-quarter 2025 projected adjusted diluted EPS excludes any non-core, unusual, or nonrecurring items. Our financial results forecasts do not include non-core items (such as mark-to-market pension and other postretirement benefit gain or loss, and asset impairments and restructuring charges) or any unusual or non-recurring items because we are unable to predict with reasonable certainty the financial impact of such items. These items are uncertain and depend on various factors, and we are unable to
later in the release …
the item shown at left
other guidance in this release
Text is the filed exhibit, verbatim.